Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Summary
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Astellas Pharma : Recognized Consistently Among Top Companies for Working Parents

09/29/2021 | 10:50am EST

NORTHBROOK, Ill. - Seramount (formerly Working Mother Media) revealed its annual list of the 2021 100 Best Companies, marking the seventh consecutive year Astellas is ranked as a top company for working moms. Astellas also earned a spot on the Best Companies for Dads for the third year in a row. This recognition highlights our inclusive benefits for families that support gender-neutral parental leave, childcare assistance, career advancement opportunities, parental school time off and flextime.

Astellas' StarLIFE program offers employees flexibility in how they do their work, robust maternity/paternity/adoption leave programs to support growing families, and a full spectrum of caregiving support for the extended family. Astellas' maternity/paternity/adoption leave programs include additional weeks of full pay, followed by a Bridge Back to Work time which eases new moms and dads back into their work schedule. Since its inception in 2015, more than half of U.S. employees have used StarLIFE services, including backup dependent care for children and parents/parents in-law, support for children with special needs, and free tutoring for children.

'As a working parent myself, I can personally speak to the amazing benefits that Astellas provides to support our working moms and dads throughout each phase of parenthood and caregiving,' said Rod Christmon, Vice President, Human Resources at Astellas. 'The recognition as a top company for working parents reinforces our commitment to fostering an inclusive workplace and culture that supports our employees to thrive in their work and family life.'

Astellas is proud to recognize our 2021 Working Mother of the Year, Carrie Schimizzi, Executive Director, Manufacturing & Operations Site Head, Astellas Gene Therapies and 2021 Working Dad of the Year Stara Wilkins, Area Sales Director, Medical Specialties, Astellas Pharma US.

Dedicated to finding and retaining top talent, Astellas empowers parents through various programs and development opportunities. The company is dedicated to continued exploration and enhancement of innovative benefits that support working parents.

ABOUT SERAMOUNT

Seramount, now part of EAB, is a strategic professional services firm dedicated to advancing diversity, equity, and inclusion in the workplace. Over four decades, partnering with some of the most iconic companies in the world, we've built a deep, data-driven understanding of the employee experience, which lays the groundwork for everything we do. Our comprehensive DE&I toolkit includes actionable research and insights, membership, strategic guidance and consulting, and inspiring events, meeting each client's needs no matter where they are on their journey and guiding them along an ever-changing landscape. Seramount has empowered over 450 organizations to realize the business benefits of diversity, equity, and inclusion. Learn more at seramount.com.

About Astellas

Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world. For more information on Astellas, please visit: https://www.astellas.com/us You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma-us.

Contact:

Jennifer Saputo

E: jennifer.saputo@astellas.com

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about ASTELLAS PHARMA INC.
12/07Astellas Applied for Selection of 'Prime Market' segment of the Tokyo Stock Exchange
AQ
12/06ASTELLAS PHARMA : New Research Organization Structure
PU
12/06ASTELLAS PHARMA : Presentation Material for R&D Meeting
PU
12/06ASTELLAS PHARMA : Corporate Governance Report
PU
12/06ASTELLAS PHARMA : Applied for Selection of “Prime Market”segment of the Tokyo ..
PU
12/06ASTELLAS PHARMA : Applied for Selection of “Prime Market” segment of the Tokyo..
PU
12/05ASTELLAS PHARMA : Corporate Covernance Report
PU
12/02Astellas to Present Research on FLT3 Mutation, Positive Acute Myeloid Leukemia from Dia..
AQ
12/02Japanese shares end lower on Omicron worries, Fed's hawkish tilt
RE
12/01Japanese shares fall on Omicron, Fed worries
RE
More news
Financials
Sales 2022 1 327 B 11 694 M 11 694 M
Net income 2022 183 B 1 612 M 1 612 M
Net cash 2022 380 B 3 348 M 3 348 M
P/E ratio 2022 17,9x
Yield 2022 2,81%
Capitalization 3 300 B 29 053 M 29 073 M
EV / Sales 2022 2,20x
EV / Sales 2023 1,93x
Nbr of Employees 15 455
Free-Float 98,9%
Chart ASTELLAS PHARMA INC.
Duration : Period :
Astellas Pharma Inc. Technical Analysis Chart | 4503 | JP3942400007 | MarketScreener
Technical analysis trends ASTELLAS PHARMA INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 1 781,00 JPY
Average target price 2 458,33 JPY
Spread / Average Target 38,0%
EPS Revisions
Managers and Directors
Kenji Yasukawa President, CEO & Representative Director
Naoki Okamura CFO, Representative Director & Vice President
Yoshihiko Hatanaka Chairman
Yoshitsugu Shitaka Chief Scientific Officer
Fumiaki Sakurai Head-Business Administration & Compliance
Sector and Competitors
1st jan.Capi. (M$)
ASTELLAS PHARMA INC.11.73%29 053
JOHNSON & JOHNSON3.80%430 061
ROCHE HOLDING AG19.17%324 115
PFIZER, INC.39.85%290 297
NOVO NORDISK A/S70.26%250 392
ELI LILLY AND COMPANY45.17%222 215